Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 1Phase 1/2 1Phase 1 1

Status

Completed 4

Sponsor Class

OTHER 16INDUSTRY 4OTHER_GOV 2NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Genitourinary 1

Conditions

Myelodysplastic Syndromes 2Prostatic Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia 1

Interventions

Carboplatin 273Paclitaxel 267Gemcitabine 244Bevacizumab 226Cisplatin 218pembrolizumab 214Docetaxel 210Pemetrexed 162Capecitabine 148Fluorouracil 129Oxaliplatin 121Cyclophosphamide 121Nivolumab 112Dexamethasone 100Trastuzumab 89Leucovorin 87Cetuximab 85Rituximab 83Irinotecan 82Injections 81Erlotinib Hydrochloride 70Prednisone 68Doxorubicin 68Temozolomide 67atezolizumab 65Bortezomib 65Ipilimumab 64Fulvestrant 59Radiotherapy 54Drug Therapy 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × INDUSTRY × treosulfan × Clear all
NCT02333058 2020-05-04

Treosulfan-based Conditioning in Paediatric Patients With Haematological Malignancies

medac GmbH

Phase 2 Completed
70 enrolled
Myeloid

Myelodysplastic Syndromes

NCT00427999 2016-11-21

INV342

Novartis

Phase 2 Completed
67 enrolled 6 charts
Genitourinary

Prostatic Neoplasms

NCT01063660 2010-02-05

Treosulfan Based Conditioning Acute Myeloid Leukaemia (AML)

medac GmbH

Phase 2 Completed
75 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01062490 2010-02-04

Treosulfan Based Conditioning Myelodysplastic Syndrome (MDS)

medac GmbH

Phase 2 Completed
45 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡